Saccomano Nicholas A — SEC Form 4 filings
SEC reporting owner CIK 1609284. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-11.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-10-08 to 2026-08-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 1,309 shares, $4,004 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 516 shares @ $2.67 ($1,378) in OnKure Therapeutics, Inc., filed 2025-04-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | President and CEO, Director | 10 | — | 7 legs · 1,309 sh · $4,004 | 19 |
Form 4 filings — Saccomano Nicholas A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-11 | 4 | OnKure Therapeutics, Inc. (OKUR) | Grant/award (A): 150,000 (derivative) @ $0 · Disposition to issuer (D): 2,359 (derivative) · Grant/award (A): 2,359 (derivative) · Disposition to issuer (D): 1,485 (derivative) · Grant/award (A): 1,485 (derivative) · Disposition to issuer (D): 8,449 (derivative) · +5 more | EDGAR |
| 2026-06-24 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 86 @ $4.40 | EDGAR |
| 2026-04-03 | 4 | OnKure Therapeutics, Inc. (OKUR) | Grant/award (A): 330,000 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 86 @ $4.16 | EDGAR |
| 2025-12-23 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 87 @ $2.97 | EDGAR |
| 2025-09-24 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 88 @ $2.62 | EDGAR |
| 2025-06-25 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 88 @ $2.38 | EDGAR |
| 2025-04-08 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 358 @ $3.33 · Sale (S): 516 @ $2.67 | EDGAR |
| 2025-01-29 | 4 | OnKure Therapeutics, Inc. (OKUR) | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2024-10-08 | 4 | OnKure Therapeutics, Inc. (OKUR) | Grant/award (A): 4,556 · Grant/award (A): 2,359 (derivative) · Grant/award (A): 1,485 (derivative) · Grant/award (A): 16,898 (derivative) · Grant/award (A): 8,449 (derivative) · Grant/award (A): 542,232 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1609284 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →